100
Participants
Start Date
November 1, 2025
Primary Completion Date
November 1, 2027
Study Completion Date
November 1, 2027
Tranexamic Acid (TXA)
Oral tranexamic acid (TXA) is administered at a dose of 1.95 grams per day, divided into three 650 mg capsules taken once daily, starting on postoperative day (POD) 1 through POD 10 (10 total doses; 30 capsules) to the treatment group.
Placebo
Participants in this arm will receive oral placebo capsules (microcrystalline cellulose), 3 capsules daily from postoperative day (POD) 1 to POD 10, for a total of 10 doses (30 capsules).
University of Pittsburgh, Pittsburgh
Duke University School of Medicine, Durham
Campbell Clinic, Germantown
University of Cincinnati, Cincinnati
Endeavor Health, Evanston
Washington University School of Medicine in St. Louis, Chesterfield
Collaborators (2)
Duke University
OTHER
University of Pittsburgh
OTHER
Endeavor Health
OTHER
University of Cincinnati
OTHER
Washington University School of Medicine
OTHER
Campbell Clinic
OTHER